Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Economic aspects All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Hepatitis B Varicella
Economic aspects All age groups Germany Mumps Measles Pertussis Varicella
Efficacy/effectiveness Safety Administration Newborn (0-1 years) Children (2-9 years) Mumps Measles Rubella Varicella
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Japanese encephalitis
Safety Newborn (0-1 years) Children (2-9 years) Mumps Measles Rubella Varicella
Efficacy/effectiveness Safety All age groups Japanese encephalitis